NYSE: HLN
Haleon PLC Earnings Dates, Reports, Calls

Haleon earnings were $1.6B for the trailing 12 months ending Jun 30, 2024, with 0.9% growth year over year. The latest HLN earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, HLN reported annual earnings of $1.3B, with 4% growth.

HLN past earnings growth

How has HLN's earnings growth performed historically?

Company
0.87%
Industry
25.6%
Market
50.24%
HLN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HLN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HLN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HLN earnings history

Current Revenue
$14.9B
Current Earnings
$1.6B
Current Profit Margin
10.7%

HLN Return on Equity

Current Company
N/A
Current Industry
10.2%
Current Market
33.7%

HLN Return on Assets

Current Company
N/A
Current Industry
3.6%

Be the first to know when HLN announces earnings.

HLN Return on Capital Employed

Current Company
7.89%
Current Industry
10.9%

HLN vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HLN$3.08B$1.61B+0.87%$0.35
TAK$8.36B$1.91B+38.93%$0.61
TEVA$1.76B-$993.00MN/A-$0.88
VTRS$2.41B-$883.30MN/A-$0.72
NBIX$549.50M$385.90M+75.78%$3.86

Haleon Earnings Reports & History FAQ

What were Haleon's earnings last quarter?

On HLN's earnings call on Invalid Date, Haleon (NYSE: HLN) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total HLN earnings for the quarter were N/A. In the same quarter last year, Haleon's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Haleon stock.

Is Haleon profitable or losing money?

As of the last Haleon earnings report, Haleon is currently profitable. Haleon's net profit (also called net income) for the twelve months ending Jun 30, 2024 was $1.59 billion, a 0.16% increase year over year.

What was HLN's earnings growth in the past year?

As of Haleon's earnings date in Invalid Date, Haleon's earnings has grown 0.87% year over year. This is 24.73 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 25.6%. HLN earnings in the past year totalled $1.61 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.